Top View
- Strategies to Obtain Diverse and Specific Human Monoclonal
- WO 2018/013551 Al 18 January 2018 (18.01.2018) W !P O PCT
- A61K9/51 (2006.01) — with International Search Report (Art
- WO 2019/028191 Al 07 February 2019 (07.02.2019) W !P O PCT
- International Nonproprietary Names (INN) for Biological and Biotechnological Substances
- CC Chemokines in a Tumor: a Review of Pro-Cancer and Anti-Cancer Properties of the Ligands of Receptors CCR1, CCR2, CCR3, and CCR4
- ( 12 ) United States Patent
- New Therapeutic Avenues for Treatment of Fibrosis: Can We Learn from Other Diseases?
- Update of Early Phase Clinical Trials in Cancer Immunotherapy
- 1 CCL2 Inhibition in Idiopathic Pulmonary Fibrosis: a Phase 2 Trial of Carlumab
- Pharmacotherapy and Adjunctive Treatment for Idiopathic Pulmonary Fibrosis (IPF)
- Harnessing the Innate Immune System and Local Immunological Microenvironment to Treat Colorectal Cancer
- CCL2) in Neat Human Sera Citation: Lacy ER, Kwok D, Baker A, Seetharam S, Chaturvedi S, Et Al
- Supplementary Tables and Figures Section 1. Distribution of CDR-H3
- Inflammation and Tumor Progression: Signaling Pathways and Targeted
- The Use of Stems in the Selection of International Nonproprietary Names (INN) for Pharmaceutical Substances
- Looking for Therapeutic Antibodies in Next Generation Sequencing Repositories
- Listes De DCI Proposées N'implique Aucune Recommandation En Vue De L'utilisation De La Substance Correspondante En Médecine Ou En Pharmacie
- New Therapeutic Avenues for Treatment of Fibrosis: Can We Learn from Other Diseases?
- Esophagitis: Drugs Picture of Iron Pill Material in Biopsy TT’S Kodachrome 1St Page Folder Iron Medication Injury Medications/Drugs
- Innate Immunity in COVID-19: Drivers of Pathogenesis and Potential Therapeutic Targets
- (INN) for Biological and Biotechnological Substances
- Tumor Microenvironment and Immunotherapy Response in Head and Neck Cancer
- WO 2015/038777 Al 19 March 2015 (19.03.2015) P O PCT
- A Study of the Safety and Efficacy of Singleagent Carlumab (An
- Supporting Information the Therapeutic Antibody Profiler (TAP): Five Computational De- Velopability Guidelines
- Edison Research Template
- Tumor-Associated Macrophages, Potential Targets for Cancer Treatment Li Yang1 and Yi Zhang1,2*
- WO 2015/036956 Al 19 March 2015 (19.03.2015) P O P C T
- Targeting the Post-Irradiation Tumor Microenvironment in Glioblastoma Via Inhibition of CXCL12
- The Role of Macrophages in Cancer Development and Therapy
- Cancer-Associated Fibroblasts: Accomplices in the Tumor Immune Evasion
- INN-Nimet 1 20.8.2019 a Abacavir Abacavirum Abakaviiri
- Open Full Page
- Orphan Drug Designations and Approvals List As of 03‐01‐2016 Governs April 1, 2016